NASDAQ:ONTX Onconova Therapeutics (ONTX) Earnings Date, Estimates & Call Transcripts $0.72 +0.00 (+0.51%) (As of 10:32 AM ET) Add Compare Share Share Today's Range$0.72▼$0.7950-Day Range$0.72▼$1.0452-Week Range$0.62▼$1.49Volume13,320 shsAverage Volume275,732 shsMarket Capitalization$15.00 millionP/E RatioN/ADividend YieldN/APrice Target$11.00 EarningsProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateNov. 13EstimatedActual EPS (Aug. 10) -$0.20 Beat By $0.09 Consensus EPS (Aug. 10) -$0.29 Read Call TranscriptListen to Call Get Onconova Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for ONTX and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueONTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ONTX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Onconova Therapeutics Analyst ForecastsQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20231($0.27)($0.27)($0.27)Q2 20231($0.29)($0.29)($0.29)Q3 20231($0.31)($0.31)($0.31)Q4 20231($0.33)($0.33)($0.33)FY 20234($1.20)($1.20)($1.20)ONTX Earnings Date and InformationOnconova Therapeutics last posted its earnings results on August 10th, 2023. The biopharmaceutical company reported ($0.20) EPS for the quarter, topping analysts' consensus estimates of ($0.29) by $0.09. The firm had revenue of $0.06 million for the quarter, compared to analysts' expectations of $0.06 million. Onconova Therapeutics has generated ($1.00) earnings per share over the last year (($1.00) diluted earnings per share). Earnings for Onconova Therapeutics are expected to grow in the coming year, from ($1.10) to ($0.82) per share. Onconova Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 13th, 2023 based off prior year's report dates.Read More Onconova Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 11/13/2023Estimated)------- 8/10/2023Q2 2023($0.29)($0.20)+$0.09($0.20)$0.06 million$0.06 million 5/15/2023Q1 2023($0.27)($0.28)($0.01)($0.28)$0.06 million$0.06 million3/16/2023Q4 2022($0.27)($0.26)+$0.01($0.26)$0.08 million$0.06 million11/14/2022Q3 2022($0.21)($0.26)($0.05)($0.26)$0.06 million$0.06 million8/11/2022Q2 2022($0.20)($0.19)+$0.01($0.19)$0.06 million$0.06 million 5/11/2022Q1 2022($0.18)($0.20)($0.02)($0.20)$0.06 million$0.06 million Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. 3/17/2022Q4 2021-($0.16)($0.16)($0.16)$0.08 million$0.06 million 11/11/2021Q3 2021($0.33)($0.22)+$0.11($0.22)$0.06 million$0.06 million 8/12/2021Q2 2021($0.28)($0.27)+$0.01($0.27)$0.04 million$0.06 million 5/17/2021Q1 2021($0.45)($0.30)+$0.15($0.02)$0.06 million$0.06 million 3/11/2021Q4 2020($0.60)($0.45)+$0.15($0.03)$0.05 million$0.06 million 11/12/2020Q3 2020($0.30)($0.45)($0.15)($0.03)$4.10 million$0.07 million Onconova Therapeutics Earnings - Frequently Asked Questions When is Onconova Therapeutics's earnings date? Onconova Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 13th, 2023 based off last year's report dates. Learn more on ONTX's earnings history. Did Onconova Therapeutics beat their earnings estimates last quarter? In the previous quarter, Onconova Therapeutics (NASDAQ:ONTX) reported ($0.20) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.29) by $0.09. Learn more on analysts' earnings estimate vs. ONTX's actual earnings. How can I listen to Onconova Therapeutics's earnings conference call? The conference call for Onconova Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read Onconova Therapeutics's conference call transcript? The conference call transcript for Onconova Therapeutics's latest earnings report can be read online. Read Transcript How much revenue does Onconova Therapeutics generate each year? Onconova Therapeutics (NASDAQ:ONTX) has a recorded annual revenue of $230,000.00. How much profit does Onconova Therapeutics generate each year? Onconova Therapeutics (NASDAQ:ONTX) has a recorded net income of -$18.96 million. ONTX has generated -$1.00 earnings per share over the last four quarters. What is Onconova Therapeutics's EPS forecast for next year? Onconova Therapeutics's earnings are expected to grow from ($1.10) per share to ($0.82) per share in the next year. More Earnings Resources from MarketBeat Related Companies: NightHawk Biosciences Earnings Date Galecto Earnings Date Aprea Therapeutics Earnings Date CalciMedica Earnings Date Nabriva Therapeutics Earnings Date RenovoRx Earnings Date Lipocine Earnings Date VBI Vaccines Earnings Date NanoViricides Earnings Date Frequency Therapeutics Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: CarMax Slides On Earnings Disappointment, Time To Celebrate?5 Oversold Semiconductor Stocks to Nibble On Ahead of Q3 EarningsDoes Ciena's Earnings Beat Signal New Networking Boom Ahead?The 5 Most Upgraded Stocks From Q2 Earnings Reporting SeasonNordstrom: 3 Reasons the Pre-Earnings Dip Is an OpportunityWhat Ross Stores Earnings Say About The Saver Shopping Economy3 Ways To Trade, Trade Desk Stock Post Earnings This page (NASDAQ:ONTX) was last updated on 10/2/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Onconova Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.